Subtopic Deep Dive
Apelin in Metabolic Disorders
Research Guide
What is Apelin in Metabolic Disorders?
Apelin in Metabolic Disorders examines the peptide apelin and its receptor APJ's roles in regulating insulin sensitivity, glucose homeostasis, adipogenesis, and energy balance in obesity and type 2 diabetes models.
Research shows apelin expression increases in adipose tissue during obesity, influencing metabolic pathways (Bertrand et al., 2015, 209 citations). Studies link gut microbiota alterations to apelin dysregulation in leptin-resistant diabetic mice (Geurts et al., 2011, 317 citations). APJ signaling modulates homeostasis disrupted in metabolic syndrome (O’Carroll et al., 2013, 323 citations).
Why It Matters
Apelin's upregulation in obesity links it to adipose tissue expansion and glucose metabolism, offering therapeutic targets for type 2 diabetes interventions (Geurts et al., 2013, 277 citations). In leptin-resistant models, gut microbiota shifts suppress apelin in adipose tissue, worsening insulin resistance and inflammation (Geurts et al., 2011). Apelin agonists could counter metabolic syndrome by enhancing energy expenditure and reducing adipogenesis, as shown in rodent studies (Bertrand et al., 2015; Wysocka et al., 2018, 244 citations). This addresses global obesity epidemics, where adipose-derived factors like apelin drive comorbidities including cardiovascular disease (Wang and Nakayama, 2010, 411 citations).
Key Research Challenges
Translating Rodent Findings to Humans
Apelin's metabolic benefits in mouse obesity models do not consistently replicate in human trials due to species differences in APJ signaling (O’Carroll et al., 2013). Adipose apelin levels vary with BMI in humans, complicating dosing (Wysocka et al., 2018). Clinical studies lack long-term data on apelin analogs' safety in diabetic patients (Recinella et al., 2020).
Gut Microbiota-Apelin Interactions
Obese microbiota reduces apelin expression in adipose tissue via endocannabinoid tone changes, but causal mechanisms remain unclear (Geurts et al., 2011). Prebiotics restore apelin but effects on glucose homeostasis vary by strain (Geurts et al., 2013). Isolating microbiota-specific apelin regulators requires advanced metagenomics (François et al., 2011).
APJ Signaling Specificity in Adipose
APJ couples to multiple G-proteins in adipocytes, yielding conflicting effects on insulin sensitivity (Bertrand et al., 2015). Inflammation from obesity alters apelin-APJ crosstalk with adipokines like adiponectin (Fisman and Tenenbaum, 2014). Selective agonists avoiding cardiovascular off-targets are undeveloped (Pope et al., 2013).
Essential Papers
Inflammation, a Link between Obesity and Cardiovascular Disease
Zhaoxia Wang, Tomohiro Nakayama · 2010 · Mediators of Inflammation · 411 citations
Obesity, the most common nutritional disorder in industrialized countries, is associated with an increased mortality and morbidity of cardiovascular disease (CVD). Obesity is primarily considered t...
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
Anne‐Marie O’Carroll, Stephen J. Lolait, Louise E. Harris et al. · 2013 · Journal of Endocrinology · 323 citations
The apelin receptor (APJ; gene symbol APLNR ) is a member of the G protein-coupled receptor gene family. Neural gene expression patterns of APJ, and its cognate ligand apelin, in the brain implicat...
Adipose tissue, obesity and adipokines: role in cancer promotion
Andrea Booth, Aaron Magnuson, Josephine K. Fouts et al. · 2015 · Hormone Molecular Biology and Clinical Investigation · 322 citations
Abstract Adipose tissue is a complex organ with endocrine, metabolic and immune regulatory roles. Adipose depots have been characterized to release several adipocytokines that work locally in an au...
Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue
Lucie Geurts, Vladimir Lazarević, Muriel Derrien et al. · 2011 · Frontiers in Microbiology · 317 citations
Growing evidence supports the role of gut microbiota in the development of obesity, type 2 diabetes, and low-grade inflammation. The endocrine activity of adipose tissue has been found to contribut...
Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics
Lucie Geurts, Audrey M. Neyrinck, Nathalie M. Delzenne et al. · 2013 · Beneficial Microbes · 277 citations
Crosstalk between organs is crucial for controlling numerous homeostatic systems (e.g. energy balance, glucose metabolism and immunity). Several pathological conditions, such as obesity and type 2 ...
Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases
Lucia Recinella, Giustino Orlando, Claudio Ferrante et al. · 2020 · Frontiers in Physiology · 244 citations
Besides its role as an energy storage organ, adipose tissue can be viewed as a dynamic and complex endocrine organ, which produces and secretes several adipokines, including hormones, cytokines, ex...
The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer
Marta Wysocka, Katarzyna Pietraszek‐Gremplewicz, Dorota Nowak · 2018 · Frontiers in Physiology · 244 citations
Apelin is an endogenous peptide identified as a ligand of the G protein-coupled receptor APJ. Apelin belongs to the family of adipokines, which are bioactive mediators released by adipose tissue. E...
Reading Guide
Foundational Papers
Start with Wang and Nakayama (2010, 411 citations) for obesity-inflammation context, then O’Carroll et al. (2013, 323 citations) for APJ biology, and Geurts et al. (2011, 317 citations) for apelin-microbiota links in adipose.
Recent Advances
Bertrand et al. (2015, 209 citations) on apelin energy metabolism; Wysocka et al. (2018, 244 citations) therapeutic roles in obesity; Recinella et al. (2020, 244 citations) adipokine targets.
Core Methods
qPCR for apelin expression in obese adipose; IPGTT for glucose homeostasis; prebiotic gnotobiotic models; G-protein coupling assays for APJ (Geurts et al., 2011; 2013).
How PapersFlow Helps You Research Apelin in Metabolic Disorders
Discover & Search
Research Agent uses searchPapers('apelin adipose tissue obesity diabetes site:frontiersin.org') to retrieve Geurts et al. (2011, 317 citations), then citationGraph reveals clusters linking gut microbiota to apelin suppression, and findSimilarPapers expands to 50+ related works on APJ in metabolic models.
Analyze & Verify
Analysis Agent applies readPaperContent on Geurts et al. (2011) to extract apelin mRNA data from leptin-resistant mice, verifyResponse with CoVe cross-checks claims against Wang and Nakayama (2010), and runPythonAnalysis plots citation trends with pandas for impact assessment; GRADE grading scores evidence as high for microbiota-apelin links.
Synthesize & Write
Synthesis Agent detects gaps in human apelin trials versus rodent data via contradiction flagging across Bertrand et al. (2015) and Wysocka et al. (2018), while Writing Agent uses latexEditText for figure captions, latexSyncCitations to integrate 20 references, and latexCompile for a review manuscript; exportMermaid visualizes APJ signaling pathways.
Use Cases
"Correlate apelin expression levels with HOMA-IR in obesity datasets from papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of Geurts 2011/2013 datasets) → matplotlib scatterplot of apelin vs. insulin resistance metrics.
"Draft LaTeX review on apelin agonists for type 2 diabetes therapeutics"
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (apelin pathway), latexSyncCitations (O’Carroll 2013 et al.), latexCompile → PDF with embedded citations and diagrams.
"Find code for apelin gene expression analysis in adipose RNA-seq data"
Research Agent → paperExtractUrls (Bertrand 2015) → Code Discovery → paperFindGithubRepo → githubRepoInspect → R script for differential expression in obesity models.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ apelin metabolic papers) → citationGraph → DeepScan(7-step verify on Geurts 2011 claims) → structured report on therapeutic potential. Theorizer generates hypotheses like 'microbiota-targeted apelin restoration prevents adipose inflammation' from Geurts 2013 + Wang 2010 synthesis. DeepScan with CoVe checkpoints validates APJ-obesity links across 2010-2020 papers.
Frequently Asked Questions
What defines Apelin in Metabolic Disorders?
Studies of apelin-APJ system in obesity, diabetes, focusing on insulin sensitivity, adipogenesis, and glucose homeostasis in adipose tissue (Bertrand et al., 2015).
What are key methods used?
Mouse models of leptin resistance measure apelin mRNA in adipose via qPCR; prebiotic interventions assess glucose tolerance; GPCR signaling assays test APJ agonists (Geurts et al., 2011; Geurts et al., 2013).
What are foundational papers?
Wang and Nakayama (2010, 411 citations) links obesity inflammation to CVD; O’Carroll et al. (2013, 323 citations) details APJ homeostasis roles; Geurts et al. (2011, 317 citations) shows microbiota-apelin dysregulation.
What open problems exist?
Human efficacy of apelin agonists unproven; microbiota-apelin causality unclear; APJ bias signaling in inflamed adipose uncharacterized (Wysocka et al., 2018; Recinella et al., 2020).
Research Apelin-related biomedical research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Apelin in Metabolic Disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers